Skip to main content
Premium Trial:

Request an Annual Quote

Berry & Associates Wins $749K SBIR Grant to Continue Developing Oligo Purification Technology

NEW YORK, April 5 (GenomeWeb News) - Berry & Associates, a privately held Michigan chemistry company, said today that it has been awarded a $ $748,727 Small Business Innovation Research grant from the National Institute of General Medical Sciences to continue its work on oligonucleotide purification.


Berry & Associates said that the new funding complements an earlier Phase I SBIR grant to develop a method of purifying oligonucleotides based on a technique known as fluorous affinity purification.


The new funding will enable the company to extend the initial work, specifically to provide specific functionality for diagnostic and therapeutic use, according to the company.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.